Analysis of Pancreatic Cystic Lesions and Risk Factors Associated with Advanced Neoplasia: Predictors Beyond Five Years of Surveillance
Digestive Diseases and Sciences · 31.10.2026
DOI: 10.1007/s10620-026-10265-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 31.10.2026. Verfasst von Daniel J Low und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Hepatology, and Nutrition Department, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, U…. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Objectives
There has been an increasing incidence of pancreatic cystic lesions on imaging. Management of pancreatic cysts has been dictated by advanced neoplasia (high-grade dysplasia or pancreas adenocarcinoma) risk; however, the appropriate surveillance strategy is not well characterized for all cyst subtypes.
Methods
A retrospective analysis was performed at MD Anderson Cancer Center evaluating pancreatic cysts identified on EUS and cross-sectional imaging between January 2000 and April 2023. Patient demographics, clinical factors, and cyst characteristics were collected. Univariate and multivariate logistic regression analyses were performed to ascertain factors predicting advanced neoplasia.
Results
3817 EUS reports were identified with 763 lesions meeting inclusion and exclusion criteria. There were 137 (18.0%) unclassified cysts, 108 (14.2%) serous cystadenomas, 494 (64.7%) IPMNs, 25 (3.33%) MCNs, and 5 (0.7%) unspecified mucinous cysts. 85 (11.1%) patients underwent surgical resection with advanced neoplasia identified in 35 (41.2%) specimens. Beyond five years of surveillance, risk factors that persisted for advanced neoplasia among all cysts included change in cyst size to ≥ 30 mm (OR 4.38; 95% CI 1.18–16.19), development of an associated mass (OR 3.97; 95% CI 1.08–14.57), and history of diabetes (OR 7.45; 95% CI 1.87–29.70). For IPMNs, risk factors after five years for advanced neoplasia included mass on final imaging (OR 13.21; 95% CI 1.51–115.49), final cyst size on imaging per-millimeter increase (OR 1.08; 95% CI 1.02–1.15), and history of diabetes (OR 12.33; 95% CI 1.99–76.34).
Conclusions
Consensus worrisome features predicted advanced neoplasia consistent with prior literature, but this baseline signal was not retained in multivariable models beyond five years of surveillance, where interval changes were the stronger predictors instead. Increasing cyst size, growth to ≥ 30 mm, and development of an associated mass remained associated with advanced neoplasia after five years. These findings suggest that interval changes in cysts should be considered in long-term risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology, Hepatology, and Nutrition Department, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
- Gastroenterology, Hepatology, and Nutrition Department, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. jefflee@mdanderson.org.
Zitieren
APA
Low, D. J., Albustami, I. S., Al-Nakshabandi, A., Shaikh, A., Weston, B. R., Coronel, E., Ge, P. S., Ross, W. A., & Lee, J. H. (2026). Analysis of Pancreatic Cystic Lesions and Risk Factors Associated with Advanced Neoplasia: Predictors Beyond Five Years of Surveillance. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10265-5
Vancouver
Low DJ, Albustami IS, Al-Nakshabandi A, Shaikh A, Weston BR, Coronel E, et al. Analysis of Pancreatic Cystic Lesions and Risk Factors Associated with Advanced Neoplasia: Predictors Beyond Five Years of Surveillance. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10265-5
BibTeX
@article{Low2026,
author = {Low, Daniel J and Albustami, Iyad S and Al-Nakshabandi, Ahmad and Shaikh, Abdullah and Weston, Brian R and Coronel, Emmanuel and Ge, Phillip S and Ross, William A and Lee, Jeffrey H},
title = {Analysis of Pancreatic Cystic Lesions and Risk Factors Associated with Advanced Neoplasia: Predictors Beyond Five Years of Surveillance},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-026-10265-5}
}
EUVIMED